RU2740096C2 - Bifidobacterium longum для лечения ожирения и ассоциированных метаболических расстройств - Google Patents

Bifidobacterium longum для лечения ожирения и ассоциированных метаболических расстройств Download PDF

Info

Publication number
RU2740096C2
RU2740096C2 RU2018119287A RU2018119287A RU2740096C2 RU 2740096 C2 RU2740096 C2 RU 2740096C2 RU 2018119287 A RU2018119287 A RU 2018119287A RU 2018119287 A RU2018119287 A RU 2018119287A RU 2740096 C2 RU2740096 C2 RU 2740096C2
Authority
RU
Russia
Prior art keywords
obesity
composition
strain
ncimb
longum ncimb
Prior art date
Application number
RU2018119287A
Other languages
English (en)
Russian (ru)
Other versions
RU2018119287A3 (enExample
RU2018119287A (ru
Inventor
Барри КЬЕЛИ
Элин Франсиз МЁРФИ
Селена ХИЛИ
Original Assignee
Элиментари Хелт Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Элиментари Хелт Лимитед filed Critical Элиментари Хелт Лимитед
Publication of RU2018119287A publication Critical patent/RU2018119287A/ru
Publication of RU2018119287A3 publication Critical patent/RU2018119287A3/ru
Application granted granted Critical
Publication of RU2740096C2 publication Critical patent/RU2740096C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
RU2018119287A 2015-12-11 2016-12-09 Bifidobacterium longum для лечения ожирения и ассоциированных метаболических расстройств RU2740096C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15199660.0 2015-12-11
EP15199660 2015-12-11
PCT/EP2016/080454 WO2017097987A1 (en) 2015-12-11 2016-12-09 Bifidobacterium longum for treating obesity and associated metabolic disorders

Publications (3)

Publication Number Publication Date
RU2018119287A RU2018119287A (ru) 2020-01-13
RU2018119287A3 RU2018119287A3 (enExample) 2020-06-30
RU2740096C2 true RU2740096C2 (ru) 2021-01-11

Family

ID=55070675

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018119287A RU2740096C2 (ru) 2015-12-11 2016-12-09 Bifidobacterium longum для лечения ожирения и ассоциированных метаболических расстройств

Country Status (14)

Country Link
US (1) US10973862B2 (enExample)
EP (1) EP3386523B1 (enExample)
JP (1) JP6843140B2 (enExample)
KR (1) KR102819885B1 (enExample)
CN (1) CN109069552B (enExample)
AU (1) AU2016368527B2 (enExample)
BR (1) BR112018011665A2 (enExample)
CA (1) CA3006176C (enExample)
DK (1) DK3386523T3 (enExample)
ES (1) ES2760076T3 (enExample)
MX (1) MX378890B (enExample)
PL (1) PL3386523T3 (enExample)
RU (1) RU2740096C2 (enExample)
WO (1) WO2017097987A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
EP3589726A1 (en) 2017-02-28 2020-01-08 Alimentary Health Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
US11833178B2 (en) 2017-08-25 2023-12-05 University College Cork—National University of Ireland, Cork Bifidobacterium longum for treating obesity and weight management
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
KR102156399B1 (ko) * 2018-04-11 2020-09-16 한국생명공학연구원 비만의 예방 또는 치료 효과를 가지는 신규 비피도박테리움 롱검 균주 또는 락토바실러스 람노서스 균주 및 이의 용도
CN113164526A (zh) 2018-07-19 2021-07-23 潘德勒姆治疗公司 用于微生物植入的方法和组合物
KR102224072B1 (ko) * 2019-08-19 2021-03-10 주식회사 빙그레 면역 조절능력과 혈중콜레스테롤 감소 능력이 모두 뛰어난 비피도박테리엄 롱검 아종 균주 및 이의 용도
EP4117697A1 (en) 2020-03-13 2023-01-18 PrecisionBiotics Group Limited Bifidobacterium longum
CN113564069B (zh) * 2021-05-28 2023-09-29 中山大学 一种长双歧杆菌、长双歧杆菌胞外多糖及其提取方法和应用
CN115466689B (zh) * 2022-02-09 2023-06-16 中国科学技术大学 用于预防和/或治疗代谢类疾病的益生菌组合物及其应用
BG67720B1 (bg) * 2022-03-18 2025-04-30 "Ел Би Булгарикум" ЕАД Щам bifidobacterium longum ssp. longum и бифидобактериален препарат с хиполипидемичен ефект, противовъзпалителен имуномодулиращ ефект и с намаляващ инсулиновата резистентност ефект
CN115637237B (zh) * 2022-09-07 2024-09-17 辽宁贝克瑞生物科技有限公司 一株长双歧杆菌及其应用
CN119073589B (zh) * 2024-02-07 2026-07-03 君乐宝乳业集团股份有限公司 一种具有促进骨骼健康功能的组合物及其应用
KR102789455B1 (ko) * 2025-02-05 2025-04-04 주식회사 리스큐어바이오사이언시스 체지방 저감, 혈당 개선 및 근육 기능 강화 활성이 우수한 비피도박테리움 롱검 아종 롱검 lbmb322020 균주 및 이를 포함하는 대사성 질환 예방, 개선 또는 치료용 조성물

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010055499A2 (en) * 2008-11-11 2010-05-20 Alimentary Health Limited Bifidobacterium longum
WO2011058535A1 (en) * 2009-11-11 2011-05-19 Alimentary Health Limited Probiotic bifidobacterium strain
RU2473681C2 (ru) * 2007-03-28 2013-01-27 Элиментари Хелт Лимитед ПРОБИОТИЧЕСКИЙ ШТАММ Bifidobacterium longum, КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ТАКОЙ ШТАММ, И ЕГО ПРИМЕНЕНИЕ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
WO2008135959A1 (en) * 2007-05-04 2008-11-13 Alimentary Health Limited An exopolysaccharide
EP2308499A1 (en) * 2009-09-30 2011-04-13 Nestec S.A. Bifidobacterium longum ATCC BAA-999 (BL999) and weight control
WO2014046804A1 (en) * 2012-09-20 2014-03-27 Prothera, Inc. Probiotic compositions and methods for the treatment of obesity and obesity-related conditions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2473681C2 (ru) * 2007-03-28 2013-01-27 Элиментари Хелт Лимитед ПРОБИОТИЧЕСКИЙ ШТАММ Bifidobacterium longum, КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ТАКОЙ ШТАММ, И ЕГО ПРИМЕНЕНИЕ
WO2010055499A2 (en) * 2008-11-11 2010-05-20 Alimentary Health Limited Bifidobacterium longum
RU2570557C2 (ru) * 2008-11-11 2015-12-10 Алиментари Хелс Лимитед ПРОБИОТИЧЕСКАЯ БИФИДОБАКТЕРИЯ Bifidobacterium Longum
WO2011058535A1 (en) * 2009-11-11 2011-05-19 Alimentary Health Limited Probiotic bifidobacterium strain

Also Published As

Publication number Publication date
CN109069552B (zh) 2023-01-24
MX2018006905A (es) 2018-08-24
US20190111090A1 (en) 2019-04-18
CA3006176C (en) 2023-10-31
BR112018011665A2 (pt) 2018-12-04
AU2016368527A1 (en) 2018-07-12
US10973862B2 (en) 2021-04-13
PL3386523T3 (pl) 2020-03-31
RU2018119287A3 (enExample) 2020-06-30
KR102819885B1 (ko) 2025-06-12
WO2017097987A1 (en) 2017-06-15
RU2018119287A (ru) 2020-01-13
CA3006176A1 (en) 2017-06-15
JP2018536427A (ja) 2018-12-13
ES2760076T3 (es) 2020-05-13
CN109069552A (zh) 2018-12-21
EP3386523A1 (en) 2018-10-17
JP6843140B2 (ja) 2021-03-17
AU2016368527B2 (en) 2023-01-12
KR20180083352A (ko) 2018-07-20
MX378890B (es) 2025-03-10
EP3386523B1 (en) 2019-10-09
DK3386523T3 (da) 2020-01-06

Similar Documents

Publication Publication Date Title
US11490643B2 (en) Lactobacillus casei for treating obesity and associated metabolic disorders
US10973862B2 (en) Bifidobacterium longum for treating obesity and associated metabolic disorders
Zhao et al. Bacillus coagulans 13002 and fructo-oligosaccharides improve the immunity of mice with immunosuppression induced by cyclophosphamide through modulating intestinal-derived and fecal microbiota
Bodera et al. Immunomodulatory effect of probiotic bacteria
IL271536A (en) Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
TWI594758B (zh) 包含雙歧桿菌的組合物、其製備方法及其用途
KR102224072B1 (ko) 면역 조절능력과 혈중콜레스테롤 감소 능력이 모두 뛰어난 비피도박테리엄 롱검 아종 균주 및 이의 용도
US20240115625A1 (en) Roseburia hominis, eubacterium eligens, and combinations thereof as biotherapeutics
Jang et al. Encapsulation of probiotics with poly-γ-glutamic acid alters gut microbiota and short-chain fatty acid content by maintaining cell viability in the gastrointestinal tract
WO2021133812A1 (en) Compositions comprising microbes and methods of use and making thereof
JP2024529268A (ja) ラクトバチルス属の菌株３種を含む組成物、およびその用途
Scarpellini et al. Probiotics: which and when?
CN115637237B (zh) 一株长双歧杆菌及其应用
HK40000357A (en) Bifidobacterium longum for treating obesity and associated metabolic disorders
HK40000368A (en) Lactobacillus casei for treating obesity and associated metabolic disorders
Zafar et al. Lacticaseibacillus rhamnosus FM9 and Limosilactobacillus fermentum Y57 Are as Effective as Statins at Improving Blood Lipid Profile in High Cholesterol, High-Fat Diet Model in Male Wistar Rats. Nutrients. 2022 Apr 15; 14 (8): 1654
Lauritano et al. Probiotics: Which and When?
BALCI PROBIOTIC NUTRITIONS, HEALTH AND OBESITY